• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前颅底侵袭性真菌感染谱的变化

Changing Spectrum of Invasive Fungal Infections of the Anterior Skull Base.

作者信息

Bhuskute Govind Shripad, Keshri Amit Kumar, Seduchidambaram Malathy, Dubey Abhishek, Hameed Nazrin, Chidambaram Kalyan, Muraleedharan Manjul, Das Kuntal Kanti, Mehrotra Anant, Srivastava Arun, Jaiswal Awadesh, Kumar Raj, Manogaran Ravi Sankar

机构信息

Neurotology Unit, Department of Neurosurgery, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.

Department of Maternal and Reproductive Health, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.

出版信息

J Neurol Surg B Skull Base. 2023 Aug 29;85(5):458-464. doi: 10.1055/a-2148-2259. eCollection 2024 Oct.

DOI:10.1055/a-2148-2259
PMID:39228884
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11368462/
Abstract

To study the etiological and anatomical factors in pathophysiology of invasive fungal rhinosinusitis affecting the skull base.  Retrospective clinical study over 5 years.  Single-center tertiary referral hospital.  All cases of invasive fungal rhinosinusitis with clinicoradiological and/or operative evidence of anterior and central skull base, orbit, and orbital apex involvement with or without intracranial disease were included in the study. Patients with a sinonasal-palatal disease without the involvement of the skull base or orbit were excluded from the study. In addition, we assessed the risk factors such as coronavirus disease 2019 (COVID-19) infection, diabetes mellitus (DM), and other immunocompromised conditions.  There were 79 patients, of which 65.8% had skull base rhino-oribitocerebral mucormycosis (ROCM), and 34.2% had infection. The mean duration from onset of the symptom to presentation of ROCM was 36.75 ± 20.97 days, while for the group was 21 weeks. The majority of patients (66%) with ROCM presented after 30 days of symptom onset. Among ROCM patients, 88.7% had a history of COVID-19 infection, and 96% had DM. In 40.8% of patients with infection, the tissue diagnosis was unavailable, and galactomannan assay and clinicoradiological assessment were used for diagnosis. The most common area of the skull base involved was the pterygopalatine fossa (88.5%), followed by the infratemporal fossa (73.1%). The most common neurovascular structure (75%) involved was the pterygopalatine ganglion and the infraorbital nerve.  With the increasing incidence of invasive fungal infections worldwide, particularly after the COVID-19 pandemic, it is crucial to understand the evolving nature of this disease. ROCM, documented in the literature to cause fulminant disease, became a chronic illness, possibly due to the improvement of the patient's immunity during the disease course.

摘要

研究侵袭性真菌性鼻-鼻窦炎累及颅底的病理生理学中的病因及解剖学因素。

  • 为期5年的回顾性临床研究。

  • 单中心三级转诊医院。

  • 本研究纳入所有具有临床放射学和/或手术证据表明累及前颅底和中颅底、眼眶及眶尖且伴有或不伴有颅内病变的侵袭性真菌性鼻-鼻窦炎病例。鼻窦-腭部疾病但未累及颅底或眼眶的患者被排除在研究之外。此外,我们评估了诸如2019冠状病毒病(COVID-19)感染、糖尿病(DM)及其他免疫功能低下状况等危险因素。

  • 共有79例患者,其中65.8%患有颅底鼻-眶-脑毛霉菌病(ROCM),34.2%患有 感染。ROCM从症状出现到确诊的平均病程为36.75±20.97天,而 组为21周。大多数ROCM患者(66%)在症状出现30天后确诊。在ROCM患者中,88.7%有COVID-19感染史,96%有DM。在40.8%的 感染患者中,无法进行组织诊断,采用半乳甘露聚糖检测及临床放射学评估进行诊断。颅底最常受累的区域是翼腭窝(88.5%),其次是颞下窝(73.1%)。最常受累的神经血管结构(75%)是翼腭神经节和眶下神经。

  • 随着全球侵袭性真菌感染发病率的上升,尤其是在COVID-19大流行之后,了解这种疾病的演变性质至关重要。文献记载ROCM可导致暴发性疾病,但它可能已成为一种慢性病,这可能是由于患者在病程中免疫力有所改善。

相似文献

1
Changing Spectrum of Invasive Fungal Infections of the Anterior Skull Base.前颅底侵袭性真菌感染谱的变化
J Neurol Surg B Skull Base. 2023 Aug 29;85(5):458-464. doi: 10.1055/a-2148-2259. eCollection 2024 Oct.
2
Skull Base Involvement in Covid Associated Rhino-Orbital-Cerebral Mucormycosis: A Comprehensive Analysis.新冠相关鼻眶脑毛霉菌病中的颅底受累:综合分析
Indian J Otolaryngol Head Neck Surg. 2023 Apr 8;75(3):1-13. doi: 10.1007/s12070-023-03717-1.
3
Magnetic resonance imaging in COVID-19-associated acute invasive fungal rhinosinusitis - Diagnosis and beyond.新型冠状病毒肺炎相关急性侵袭性真菌性鼻-鼻窦炎的磁共振成像——诊断及其他
J Clin Imaging Sci. 2023 Aug 9;13:23. doi: 10.25259/JCIS_46_2023. eCollection 2023.
4
A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.真菌性传染病在病毒性传染病大流行期间:印度 COVID-19 相关的鼻眶脑毛霉菌病发病的危险因素。
Orbit. 2023 Feb;42(1):30-41. doi: 10.1080/01676830.2021.2020851. Epub 2022 Feb 22.
5
The changing trend of fungal infection in invasive rhinosinusitis in the COVID era.新冠疫情时代侵袭性鼻-鼻窦炎真菌感染的变化趋势
J Family Med Prim Care. 2024 Apr;13(4):1428-1433. doi: 10.4103/jfmpc.jfmpc_871_23. Epub 2024 Apr 22.
6
Imaging findings in invasive rhino-orbito-cerebral mucormycosis in post-COVID-19 patients.新冠后患者侵袭性鼻眶脑型毛霉菌病的影像学表现
Proc (Bayl Univ Med Cent). 2021 Sep 30;35(1):32-34. doi: 10.1080/08998280.2021.1981100. eCollection 2022.
7
Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.印度 2826 例 COVID-19 相关的鼻-眶-脑毛霉菌病的流行病学、临床特征、治疗和结局 - 合作 OPAI-IJO 新冠病毒相关毛霉菌病研究(COSMIC),报告 1。
Indian J Ophthalmol. 2021 Jul;69(7):1670-1692. doi: 10.4103/ijo.IJO_1565_21.
8
Emergence of Invasive Fungal Rhinosinusitis in Recently Recovered COVID-19 Patients.COVID-19 康复患者中侵袭性真菌性鼻-鼻窦炎的发生。
Ann Otol Rhinol Laryngol. 2022 Nov;131(11):1202-1209. doi: 10.1177/00034894211060923. Epub 2021 Dec 1.
9
MR Imaging in Covid-19-Associated Invasive Fungal Sinusitis.Covid-19 相关侵袭性真菌性鼻窦炎的磁共振成像。
Neurol India. 2024 Sep 1;72(5):1009-1015. doi: 10.4103/neurol-india.ni_1225_21. Epub 2024 Oct 19.
10
Magnetic Resonance Imaging in Coronavirus Disease - 2019 Associated Rhino-Orbital-Cerebral Mucormycosis (CA-ROCM) - Imaging Analysis of 50 Consecutive Patients.磁共振成像在冠状病毒病 2019 相关的鼻眶脑毛霉菌病(CA-ROCM)中的应用 - 50 例连续患者的影像学分析。
Curr Probl Diagn Radiol. 2022 Jan-Feb;51(1):112-120. doi: 10.1067/j.cpradiol.2021.09.004. Epub 2021 Nov 3.

引用本文的文献

1
The Potential Diagnostic Trap of Unexpected Intracranial Hyalohyplymycosis-A Case Report and Brief Literature Review.意外性颅内透明质菌病的潜在诊断陷阱——病例报告及文献简要综述
J Clin Med. 2025 Apr 10;14(8):2594. doi: 10.3390/jcm14082594.
2
Fungal skull base lesion masquerading as malignancy: a diagnostic dilemma. Illustrative case report.伪装成恶性肿瘤的真菌性颅底病变:诊断难题。病例报告。
Ann Med Surg (Lond). 2024 Dec 20;87(2):929-933. doi: 10.1097/MS9.0000000000002964. eCollection 2025 Feb.

本文引用的文献

1
Current treatments against mucormycosis and future directions.当前针对毛霉病的治疗方法和未来方向。
PLoS Pathog. 2022 Oct 13;18(10):e1010858. doi: 10.1371/journal.ppat.1010858. eCollection 2022 Oct.
2
Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.是否意味着毛霉菌病的终结?COVID 相关的鼻-眶-脑毛霉菌病的全面管理:保留可挽救的。
Eur Arch Otorhinolaryngol. 2023 Feb;280(2):819-827. doi: 10.1007/s00405-022-07620-3. Epub 2022 Sep 2.
3
The Spectrum of Invasive Fungal Sinusitis in COVID-19 Patients: Experience from a Tertiary Care Referral Center in Northern India.新冠患者侵袭性真菌性鼻窦炎的谱系:来自印度北部一家三级医疗转诊中心的经验
J Fungi (Basel). 2022 Feb 24;8(3):223. doi: 10.3390/jof8030223.
4
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries.COVID-19 相关毛霉病的出现:来自 18 个国家的病例回顾。
Lancet Microbe. 2022 Jul;3(7):e543-e552. doi: 10.1016/S2666-5247(21)00237-8. Epub 2022 Jan 25.
5
Neurological infections in 2021: a spotlight on India.2021年的神经系统感染:聚焦印度
Lancet Neurol. 2022 Jan;21(1):17-18. doi: 10.1016/S1474-4422(21)00415-4.
6
Steroids use in non-oxygen requiring COVID-19 patients: a systematic review and meta-analysis.非需氧 COVID-19 患者中使用类固醇:系统评价和荟萃分析。
QJM. 2021 Nov 5;114(7):455-463. doi: 10.1093/qjmed/hcab212.
7
Mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum.全球新冠疫情背景下的毛霉病合并感染:大流行谱中的致命新增情况
Int J Surg. 2021 Aug;92:106031. doi: 10.1016/j.ijsu.2021.106031. Epub 2021 Jul 24.
8
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.COVID-19 相关毛霉菌病:全球及印度病例报告的系统综述。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102146. doi: 10.1016/j.dsx.2021.05.019. Epub 2021 May 21.
9
Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.印度 2826 例 COVID-19 相关的鼻-眶-脑毛霉菌病的流行病学、临床特征、治疗和结局 - 合作 OPAI-IJO 新冠病毒相关毛霉菌病研究(COSMIC),报告 1。
Indian J Ophthalmol. 2021 Jul;69(7):1670-1692. doi: 10.4103/ijo.IJO_1565_21.
10
SARS-CoV-2, Uncontrolled Diabetes and Corticosteroids-An Unholy Trinity in Invasive Fungal Infections of the Maxillofacial Region? A Retrospective, Multi-centric Analysis.严重急性呼吸综合征冠状病毒2型、未控制的糖尿病与皮质类固醇——颌面区域侵袭性真菌感染中的“邪恶三位一体”?一项回顾性多中心分析
J Maxillofac Oral Surg. 2021 Sep;20(3):418-425. doi: 10.1007/s12663-021-01532-1. Epub 2021 Mar 6.